The impact of using primaquine without prior G6PD testing: a case series describing the obstacles to the medical management of haemolysis
<br/>Radical cure of Plasmodium vivax malaria in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals employs weekly primaquine dosing. This is the only recommended regimen for this patient sub-group. If national malaria programs mandate daily primaquine dosing (the recommended regim...
| Main Authors: | , , , , , |
|---|---|
| Format: | Journal article |
| Published: |
F1000Research
2019
|